Terms: = Bone cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Prognosis
14 results:
1. A global study for acute myeloid leukemia with RARG rearrangement.
Zhu HH; Qin YZ; Zhang ZL; Liu YJ; Wen LJ; You MJ; Zhang C; Such E; Luo H; Yuan HJ; Zhou HS; Liu HX; Xu R; Li J; Li JH; Hao JP; Jin J; Yu L; Zhang JY; Liu LP; Zhang LP; Huang RB; Shen SH; Gao SJ; Wang W; Yan XJ; Zhang XY; Du X; Chu XX; Yu YF; Wang Y; Mi YC; Lu Y; Cai Z; Su Z; Taussig DC; MacMahon S; Ball ED; Wang HY; Welch JS; Yin CC; Borthakur G; Sanz MA; Kantarjian HM; Huang JY; Hu J; Chen SN
Blood Adv; 2023 Jul; 7(13):2972-2982. PubMed ID: 36799929
[TBL] [Abstract] [Full Text] [Related]
2. RBCK1-TRIB3 decelerated the progression of acute promyelocytic leukemia.
Zhang X; Yu W
Hematol Oncol; 2021 Oct; 39(4):567-569. PubMed ID: 34310740
[TBL] [Abstract] [Full Text] [Related]
3. No prognostic significance of normalized copy number of pml-RARA transcript at diagnosis in patients with acute promyelocytic leukemia.
Rasekh EO; Elsayed GM; Fathy S
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):119-125. PubMed ID: 32735792
[TBL] [Abstract] [Full Text] [Related]
4. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
[TBL] [Abstract] [Full Text] [Related]
5. Role of minimal residual disease in the management of acute myeloid leukemia-a case-based discussion.
Coltoff A; Houldsworth J; Keyzner A; Renteria AS; Mascarenhas J
Ann Hematol; 2018 Jul; 97(7):1155-1167. PubMed ID: 29704019
[TBL] [Abstract] [Full Text] [Related]
6. May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report.
Anastasi E; Porpora MG; Pecorella I; Bernardo S; Frati L; Benedetti Panici P; Manganaro L
Tumour Biol; 2014 Jul; 35(7):6969-71. PubMed ID: 24740561
[TBL] [Abstract] [Full Text] [Related]
7. Incidence and prognostic importance of molecular genetic defects in children with acute myeloblastic leukemia.
Kömür M; Erbey F; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2010; 11(5):1393-5. PubMed ID: 21198299
[TBL] [Abstract] [Full Text] [Related]
8. Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells.
Naka K; Hoshii T; Hirao A
Cancer Sci; 2010 Jul; 101(7):1577-81. PubMed ID: 20491777
[TBL] [Abstract] [Full Text] [Related]
9. [Biochemical bone resorption markers in children with osteosarcoma].
Ambroszkiewicz J; Gajewska J; Laskowska-Klita T; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):225-33. PubMed ID: 15738598
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of genetic changes between interphase and metaphase nuclei in monitoring CML and APL treatment using DC-FISH technique.
Yakut T; Ali R; Egeli U; Ozkalemkas F; Ercan I; Ozçelik T; Ozkocaman V; Yigit B; Tunali A
Cancer Biol Ther; 2004 Sep; 3(9):858-63. PubMed ID: 15254420
[TBL] [Abstract] [Full Text] [Related]
11. Deletion of chromosome 15 represents a rare but recurrent chromosomal abnormality in myelocytic malignancies.
Dierlamm J; Schilling G; Michaux L; Hinz K; Murga Penas EM; Seeger D; Hagemeijer A; Hossfeld DK
Cancer Genet Cytogenet; 2003 Jul; 144(1):1-5. PubMed ID: 12810248
[TBL] [Abstract] [Full Text] [Related]
12. New advances in the treatment of acute promyelocytic leukemia.
Douer D
Int J Hematol; 2002 Aug; 76 Suppl 2():179-87. PubMed ID: 12430923
[TBL] [Abstract] [Full Text] [Related]
13. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract] [Full Text] [Related]
14. [The genetic diagnosis of hematopoietic malignancy by polymerase chain reaction method].
Yokota H; Kitamura K
Rinsho Byori; 2000 Aug; 48(8):708-15. PubMed ID: 11064593
[TBL] [Abstract] [Full Text] [Related]
